Cellavision Q1 2025: EMEA Drove Sales Growth - Redeye

Redeye comments on Cellavision's first quarter 2025, which saw organic sales growth of 14%, an outstanding figure. Growth was mainly driven by instrument sales in EMEA. The outlook for the rest of the year is positive, with the caveat that an appreciating SEK will have a negative effect on the final growth rate.

Länk till analysen i sin helhet: https://www.redeye.se/research/1102490/cellavision-q1-2025-emea-drove-sales-growth?utm_source=finwire&utm_medium=RSS